OBJECTIVE: To assess the cost-effectiveness of addition of ST analysis of the fetal electrocardiogram (ECG; STAN) to cardiotocography (CTG) for fetal surveillance during labor compared with CTG only. DESIGN:Cost-effectiveness analysis based on a randomized clinical trial on ST analysis of the fetal ECG. SETTING:Obstetric departments of three academic and six general hospitals in The Netherlands. Population. Laboring women with a singleton high-risk pregnancy, a fetus in cephalic presentation, a gestational age >36 weeks and an indication for internal electronic fetal monitoring. METHODS: A trial-based cost-effectiveness analysis was performed from a health-care provider perspective. MAIN OUTCOME MEASURES: Primary health outcome was the incidence of metabolic acidosis measured in the umbilical artery. Direct medical costs were estimated from start of labor to childbirth. Cost-effectiveness was expressed as costs to prevent one case of metabolic acidosis. RESULTS: The incidence of metabolic acidosis was 0.7% in the ST-analysis group and 1.0% in the CTG-only group (relative risk 0.70; 95% confidence interval 0.38-1.28). Per delivery, the mean costs per patient of CTG plus ST analysis (n= 2 827) were €1,345 vs. €1,316 for CTG only (n= 2 840), with a mean difference of €29 (95% confidence interval -€9 to €77) until childbirth. The incremental costs of ST analysis to prevent one case of metabolic acidosis were €9 667. CONCLUSIONS: The additional costs of monitoring by ST analysis of the fetal ECG are very limited when compared with monitoring by CTG only and very low compared with the total costs of delivery.
RCT Entities:
OBJECTIVE: To assess the cost-effectiveness of addition of ST analysis of the fetal electrocardiogram (ECG; STAN) to cardiotocography (CTG) for fetal surveillance during labor compared with CTG only. DESIGN: Cost-effectiveness analysis based on a randomized clinical trial on ST analysis of the fetal ECG. SETTING: Obstetric departments of three academic and six general hospitals in The Netherlands. Population. Laboring women with a singleton high-risk pregnancy, a fetus in cephalic presentation, a gestational age >36 weeks and an indication for internal electronic fetal monitoring. METHODS: A trial-based cost-effectiveness analysis was performed from a health-care provider perspective. MAIN OUTCOME MEASURES: Primary health outcome was the incidence of metabolic acidosis measured in the umbilical artery. Direct medical costs were estimated from start of labor to childbirth. Cost-effectiveness was expressed as costs to prevent one case of metabolic acidosis. RESULTS: The incidence of metabolic acidosis was 0.7% in the ST-analysis group and 1.0% in the CTG-only group (relative risk 0.70; 95% confidence interval 0.38-1.28). Per delivery, the mean costs per patient of CTG plus ST analysis (n= 2 827) were €1,345 vs. €1,316 for CTG only (n= 2 840), with a mean difference of €29 (95% confidence interval -€9 to €77) until childbirth. The incremental costs of ST analysis to prevent one case of metabolic acidosis were €9 667. CONCLUSIONS: The additional costs of monitoring by ST analysis of the fetal ECG are very limited when compared with monitoring by CTG only and very low compared with the total costs of delivery.
Authors: Nicola J Robertson; Sidhartha Tan; Floris Groenendaal; Frank van Bel; Sandra E Juul; Laura Bennet; Matthew Derrick; Stephen A Back; Raul Chavez Valdez; Frances Northington; Alistair Jan Gunn; Carina Mallard Journal: J Pediatr Date: 2012-02-09 Impact factor: 4.406
Authors: Adeline A Boatin; Blair Wylie; Ilona Goldfarb; Robin Azevedo; Elena Pittel; Courtney Ng; Jessica Haberer Journal: PLoS One Date: 2015-01-26 Impact factor: 3.240
Authors: Marit Hitzert; Marieke Maa Hermus; Inge Ic Boesveld; Arie Franx; Karin Km van der Pal-de Bruin; Eric Eap Steegers; EIske Me van den Akker-van Marle Journal: BMJ Open Date: 2017-09-11 Impact factor: 2.692
Authors: Liv Freeman; Johanna Middeldorp; Eline van den Akker; Martijn Oudijk; Caroline Bax; Marloes van Huizen; Celine Radder; Bianca Fong; Kitty Bloemenkamp; Albert Dahan; Michel Struys; Ben Willem Mol; Jan van Lith; Elske van den Akker-van Marle Journal: PLoS One Date: 2018-10-11 Impact factor: 3.240
Authors: Jens Henrichs; Ank de Jonge; Myrte Westerneng; Viki Verfaille; Arie Franx; Henriëtte E van der Horst; Judith E Bosmans Journal: Int J Environ Res Public Health Date: 2022-03-11 Impact factor: 3.390